X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs LUPIN LTD - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD LUPIN LTD ALEMBIC LTD/
LUPIN LTD
 
P/E (TTM) x 122.8 19.9 617.1% View Chart
P/BV x 4.6 2.7 169.1% View Chart
Dividend Yield % 0.2 0.9 26.5%  

Financials

 ALEMBIC LTD   LUPIN LTD
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
LUPIN LTD
Mar-17
ALEMBIC LTD/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs531,750 3.0%   
Low Rs291,384 2.1%   
Sales per share (Unadj.) Rs4.7387.4 1.2%  
Earnings per share (Unadj.) Rs8.856.6 15.5%  
Cash flow per share (Unadj.) Rs9.076.8 11.7%  
Dividends per share (Unadj.) Rs0.157.50 2.0%  
Dividend yield (eoy) %0.40.5 76.3%  
Book value per share (Unadj.) Rs27.7298.9 9.3%  
Shares outstanding (eoy) m267.03451.58 59.1%   
Bonus/Rights/Conversions -ESOPS-  
Price / Sales ratio x8.74.0 215.1%   
Avg P/E ratio x4.727.7 16.9%  
P/CF ratio (eoy) x4.620.4 22.4%  
Price / Book Value ratio x1.55.2 28.2%  
Dividend payout %1.713.2 12.9%   
Avg Mkt Cap Rs m10,962707,513 1.5%   
No. of employees `000NA16.8 0.0%   
Total wages/salary Rs m23828,495 0.8%   
Avg. sales/employee Rs ThNM10,418.3-  
Avg. wages/employee Rs ThNM1,697.0-  
Avg. net profit/employee Rs ThNM1,523.0-  
INCOME DATA
Net Sales Rs m1,260174,943 0.7%  
Other income Rs m2641,065 24.8%   
Total revenues Rs m1,524176,008 0.9%   
Gross profit Rs m8344,931 0.2%  
Depreciation Rs m619,122 0.7%   
Interest Rs m01,525 0.0%   
Profit before tax Rs m28535,349 0.8%   
Minority Interest Rs m0-72 0.0%   
Prior Period Items Rs m2,09683 2,540.8%   
Extraordinary Inc (Exp) Rs m-320-   
Tax Rs m69,785 0.1%   
Profit after tax Rs m2,34325,575 9.2%  
Gross profit margin %6.625.7 25.6%  
Effective tax rate %2.127.7 7.7%   
Net profit margin %185.914.6 1,271.6%  
BALANCE SHEET DATA
Current assets Rs m1,689119,542 1.4%   
Current liabilities Rs m48661,206 0.8%   
Net working cap to sales %95.433.3 286.2%  
Current ratio x3.52.0 177.8%  
Inventory Days Days21776 285.5%  
Debtors Days Days8190 90.2%  
Net fixed assets Rs m1,624131,660 1.2%   
Share capital Rs m534903 59.1%   
"Free" reserves Rs m5,960134,073 4.4%   
Net worth Rs m7,404134,976 5.5%   
Long term debt Rs m10456,478 0.2%   
Total assets Rs m8,010266,073 3.0%  
Interest coverage x950.724.2 3,932.4%   
Debt to equity ratio x00.4 3.4%  
Sales to assets ratio x0.20.7 23.9%   
Return on assets %29.310.2 287.2%  
Return on equity %31.618.9 167.0%  
Return on capital %31.319.3 162.4%  
Exports to sales %2.90-   
Imports to sales %28.90-   
Exports (fob) Rs m37NA-   
Imports (cif) Rs m364NA-   
Fx inflow Rs m3781,885 0.0%   
Fx outflow Rs m36521,506 1.7%   
Net fx Rs m-32860,378 -0.5%   
CASH FLOW
From Operations Rs m34641,148 0.8%  
From Investments Rs m-48-25,287 0.2%  
From Financial Activity Rs m-3014,332 -6.9%  
Net Cashflow Rs m-320,193 -0.0%  

Share Holding

Indian Promoters % 64.0 46.6 137.3%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 0.2 11.3 1.8%  
FIIs % 9.7 31.9 30.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 10.1 258.4%  
Shareholders   54,701 98,259 55.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   SANOFI INDIA  ABBOTT INDIA  FRESENIUS KABI ONCO.  CIPLA  ASTRAZENECA PHARMA  

Compare ALEMBIC LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Chart Modest Gains(RoundUp)

Global financial markets ended the holiday shortened week with modest gains. The rally put behind days of decline as concerns regarding swift interest rates hikes were put to ease.

Related Views on News

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Feb 23, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS